RNAi-mediated down-regulation of α-actinin-4 decreases invasion potential in oral squamous cell carcinoma

International Journal of Oral and Maxillofacial Surgery

Volumn 39, Issue 1, 2010, Pages 61-67

  Yamada, S ^a   Yanamoto, S ^a   Yoshida, H ^a   Yoshitomi, I ^a   Kawasaki, G ^a   Mizuno, A ^a   Nemoto, T K ^b  

^a Unit of Translational Medicine

^b Department of Oral Molecular Biology

Author keywords

actinin 4; invasion; metastasis; oral squamous cell carcinoma; RNA interference

Indexed keywords

ALPHA ACTININ 4; SMALL INTERFERING RNA;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER INVASION; CELL ASSAY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH MUCOSA; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA;

ACTININ; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; DIFFUSION CHAMBERS, CULTURE; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 74149093658     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2009.10.003     Document Type: Article

References (30)

1. Araki N., Hatae T., Yamada T., and Hirohashi S. Actinin-4 is preferentially involved in circular ruffling and macropinocytosis in mouse macrophages: analysis by fluorescence ratio imaging. J Cell Sci 113 (2000) 3329-3340
2. Arora S, Kaur J, Sharma C, Mathur M, Bahadur S, Shukla NK, Deo SV, Ralhan R. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Clin Cancer Res 2005:11:2272-2284.
3. Bánkfalvi A., Krassort M., Buchwalow I.B., Végh A., Felszeghy E., and Piffkó J. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression. J Pathol 198 (2002) 343-351
4. Beggs A.H., Byers T.J., Knoll J.H., Boyce F.M., Bruns G.A., and Kunkel L.M. Cloning and characterization of two human skeletal muscle alpha-actinin genes located on chromosomes 1 and 11. J Biol Chem 267 (1992) 9281-9288
5. Bryne M., Boysen M., Alfsen C.G., Abeler V.M., Sudbø J., Nesland J.M., Kristensen G.B., Piffko J., and Bankfalvi A. The invasive front of carcinomas. The most important area for tumour prognosis?. Anticancer Res 18 (1998) 4757-4764
6. Buccione R., Orth J.D., and McNiven M.A. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat Rev Mol Cell Biol 5 (2004) 647-657
7. Clark W.A. Evidence for post-translational kinetic compartmentation of protein turnover pools in isolated adult cardiac myocytes. J Biol Chem 25 (1993) 20243-20251
8. Echchakir H., Mami-Chouaib F., Vergnon I., Baurain J.F., Karanikas V., Chouaib S., and Coulie P.G. A point mutation in the alpha-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma. Cancer Res 61 (2001) 4078-4083
9. Fu L., Qin Y.R., Xie D., Chow H.Y., Ngai S.M., Kwong D.L., Li Y., and Guan X.Y. Identification of alpha-actinin 4 and 67 kDa laminin receptor as stage-specific markers in esophageal cancer via proteomic approaches. Cancer 110 (2007) 2672-2681
10. Glück U., and Ben-Ze'ev A. Modulation of alpha-actinin levels affects cell motility and confers tumorigenicity on 3T3 cells. J Cell Sci 107 (1994) 1773-1782
11. González-García R., Naval-Gías L., Rodríguez-Campo F.J., Sastre-Pérez J., Muñoz-Guerra M.F., and Gil-Díez Usandizaga J.L. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients. J Oral Maxillofac Surg 66 (2008) 1390-1398
12. Hara T., Honda K., Shitashige M., Ono M., Matsuyama H., Naito K., Hirohashi S., and Yamada T. Mass spectrometry analysis of the native protein complex containing actinin-4 in prostate cancer cells. Mol Cell Proteomics 6 (2007) 479-491
13. Hayashida Y., Honda K., Idogawa M., Ino Y., Ono M., Tsuchida A., Aoki T., Hirohashi S., and Yamada T. E-cadherin regulates the association between beta-catenin and actinin-4. Cancer Res 65 (2005) 8836-8845
14. Hicks Jr. W.L., North Jr. J.H., Loree T.R., Maamoun S., Mullins A., Orner J.B., Bakamjian V.Y., and Shedd D.P. Surgery as a single modality therapy for squamous cell carcinoma of the oral tongue. Am J Otolaryngol 19 (1998) 24-28
15. Honda K., Yamada T., Endo R., Ino Y., Gotoh M., Tsuda H., Yamada Y., Chiba H., and Hirohashi S. Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol 140 (1998) 1383-1393
16. Honda K., Yamada T., Seike M., Hayashida Y., Idogawa M., Kondo T., Ino Y., and Hirohashi S. Alternative splice variant of actinin-4 in small cell lung cancer. Oncogene 23 (2004) 5257-5262
17. Honda K., Yamada T., Hayashida Y., Idogawa M., Sato S., Hasegawa F., Ino Y., Ono M., and Hirohashi S. Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology 128 (2005) 51-62
18. Knudsen K.A., Soler A.P., Johnson K.R., and Wheelock M.J. Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin. J Cell Biol 130 (1995) 67-77
19. Kudo Y., Kitajima S., Ogawa I., Kitagawa M., Miyauchi M., and Takata T. Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation. Mol Cancer Ther 4 (2005) 471-476
20. Mao L., Hong W.K., and Papadimitrakopoulou V.A. Focus on head and neck cancer. Cancer Cell 5 (2004) 311-316
21. Maruyama K., and Ebashi S. Alpha-actinin, a new structural protein from striated muscle. II. Action on actin. J Biochem 58 (1965) 13-19
22. Nikolopoulos S.N., Spengler B.A., Kisselbach K., Evans A.E., Biedler J.L., and Ross R.A. The human non-muscle alpha-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells. Oncogene 19 (2000) 380-386
23. Otey C.A., Pavalko F.M., and Burridge K. An interaction between alpha-actinin and the beta 1 integrin subunit in vitro. J Cell Biol 111 (1990) 721-729
24. Pupa S.M., Ménard S., Forti S., and Tagliabue E. New insights into the role of extracellular matrix during tumor onset and progression. J Cell Physiol 192 (2002) 259-267
25. Sessions D.G., Lenox J., Spector G.J., Chao C., and Chaudry O.A. Analysis of treatment results for base of tongue cancer. Laryngoscope 113 (2003) 1252-1261
26. Tuschl T. Expnading small RNA interference. Nature Biotech 20 (2002) 446-448
27. Yamamoto S., Tsuda H., Honda K., Kita T., Takano M., Tamai S., Inazawa J., Yamada T., and Matsubara O. Actinin-4 expression in ovarian cancer: a novel prognostic indicator independent of clinical stage and histological type. Mod Pathol 20 (2007) 1278-1285
28. Yanamoto S., Iwamoto T., Kawasaki G., Yoshitomi I., Baba N., and Mizuno A. Silencing of the p53R2 gene by RNA interference inhibits growth and enhances 5-fluorouracil sensitivity of oral cancer cells. Cancer Lett 223 (2005) 67-76
29. Yanamoto S., Kawasaki G., Yoshitomi I., Iwamoto T., Hirata K., and Mizuno A. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy. Oral Oncol 43 (2007) 869-877
30. Ziober B.L., Silverman Jr. S.S., and Kramer R.H. Adhesive mechanisms regulating invasion and metastasis in oral cancer. Crit Rev Oral Biol Med 12 (2001) 499-510